CG Oncology (CGON) FCF Margin (2023 - 2026)
CG Oncology (CGON) reported FCF Margin of 5281.99% for Q1 2026, up 5105070.0% on a YoY basis from N/an in Q1 2025, and down 238.31% quarter-over-quarter from 1561.28% in Q4 2025.
CG Oncology (CGON) FCF Margin (2023 - 2026) Analysis & Trends
CG Oncology has reported FCF Margin for 4 years, with the latest figure at 5281.99% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 5105070.0% year-over-year to 5281.99%; the trailing twelve-month figure through Mar 2026 stood at 3162.91% (up 925643.0% YoY), and the FY2025 full-year result was 3279.21%, up 365205.0% from the prior year.
- FCF Margin for Q1 2026 stood at 5281.99%, down from 1561.28% in the prior quarter.
- The five-year high for FCF Margin was 1561.28% in Q4 2025, with the low at 1464500.0% in Q4 2023.
- Historically, FCF Margin has averaged 157402.53% across 4 years, with a median of 5281.99% in 2026.
- Annual changes were most pronounced in 2024 — FCF Margin surged 145992303 bps — and 2025, when it plunged 5141322 bps.
- CG Oncology's FCF Margin stood at 1464500.0% in 2023, then jumped by 100 bps to 4576.97% in 2024, then surged by 66 bps to 1561.28% in 2025, then plunged by 238 bps to 5281.99% in 2026.
- The last three FCF Margin figures came in at 5281.99% (Q1 2026), 1561.28% (Q4 2025), and 2340.76% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | CG Oncology | 5.16 Bn | 5.16 Bn | -1.88 Mn | -5,281.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,281.99% |
| Dec 31, 2025 | -1,561.28% |
| Sep 30, 2025 | -2,340.76% |
| Mar 31, 2025 | -56,332.69% |
| Dec 31, 2024 | -4,576.97% |
| Sep 30, 2024 | -37,018.60% |
| Jun 30, 2024 | -14,535.14% |
| Mar 31, 2024 | -4,919.47% |
| Dec 31, 2023 | -1,464,500.00% |
| Sep 30, 2023 | -136,244.44% |
| Mar 31, 2023 | -4,116.49% |